Indegene sets up Portugal subsidiary to establish presence in Portugal

Mergers & acquisitions
life sciences services

Blacklitt Research26 October 20262 min read

Indegene (NSE: INDGN) has incorporated INDEGENE PORTUGAL, UNIPESSOAL LDA, a step-down wholly owned subsidiary, to establish presence in Portugal, it said in a filing on 26 Oct 2026. The entity was incorporated on 23 Oct 2026 and is held 100% by Indegene Ireland Limited, a wholly owned subsidiary of the company.

The subsidiary's stated business and structure

INDEGENE PORTUGAL, UNIPESSOAL LDA was incorporated in Portugal on 23 Oct 2026. Indegene Ireland Limited, a wholly owned subsidiary of Indegene, holds 100% of its share capital.

The stated business covers services for the life sciences, healthcare and biopharmaceutical sectors, corporate services for other affiliated entities, content development and technology support, support services for clinical development and medical affairs, and support services for medical education and communications.

The subsidiary's turnover is nil and it is yet to begin operations. The company received the communication confirming the incorporation on 26 Oct 2026. No governmental or regulatory approvals are applicable, and there are no related party transactions as the subsidiary has not started operations.

How it fits Indegene

Indegene's latest reported quarter, Q1 FY27 on a consolidated basis, shows total income of ₹1,092.10 crore, up 39.5% year on year. Against that size, the subsidiary has no revenue yet and its capital is not stated in the filing.

What the subsidiary means for Indegene's shareholders

The step adds a Portuguese entity under the Irish subsidiary, with no turnover so far. The filing does not state the initial share capital, the amount invested by the company or its Irish subsidiary, funding plans beyond the initial capital, when operations will start, or whether the business differs from the group's existing business.

At a glance

Item	Detail
Subsidiary	INDEGENE PORTUGAL, UNIPESSOAL LDA
Incorporated	23 Oct 2026
Holding	100% by Indegene Ireland Limited
Stated business	Life sciences, healthcare and biopharma support services
Turnover	Nil; yet to begin operations

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.